Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action.

combination anticancer therapy vit-A vit-C vit-D vit-E

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2023
Historique:
received: 23 08 2023
accepted: 09 11 2023
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 26 1 2024
Statut: epublish

Résumé

Cancer, a leading global cause of mortality, arises from intricate interactions between genetic and environmental factors, fueling uncontrolled cell growth. Amidst existing treatment limitations, vitamins have emerged as promising candidates for cancer prevention and treatment. This review focuses on Vitamins A, C, E, and D because of their protective activity against various types of cancer. They are essential as human metabolic coenzymes. Through a critical exploration of preclinical and clinical studies via PubMed and Google Scholar, the impact of these vitamins on cancer therapy was analyzed, unraveling their complicated mechanisms of action. Interestingly, vitamins impact immune function, antioxidant defense, inflammation, and epigenetic regulation, potentially enhancing outcomes by influencing cell behavior and countering stress and DNA damage. Encouraging clinical trial results have been observed; however, further well-controlled studies are imperative to validate their effectiveness, determine optimal dosages, and formulate comprehensive cancer prevention and treatment strategies. Personalized supplementation strategies, informed by medical expertise, are pivotal for optimal outcomes in both clinical and preclinical contexts. Nevertheless, conclusive evidence regarding the efficacy of vitamins in cancer prevention and treatment is still pending, urging further research and exploration in this compelling area of study.

Identifiants

pubmed: 38274206
doi: 10.3389/fnut.2023.1281879
pmc: PMC10808607
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1281879

Informations de copyright

Copyright © 2024 Talib, Ahmed Jum’AH, Attallah, Jallad, Al Kury, Hadi and Mahmod.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Wamidh H Talib (WH)

Faculty of Allied Medical Sciences, Applied Science Private University, Amman, Jordan.

Dima Abdulraheem Ahmed Jum'AH (DA)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman, Jordan.

Zeena Shamil Attallah (ZS)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman, Jordan.

Mohanned Sami Jallad (MS)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman, Jordan.

Lina T Al Kury (LT)

Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi, United Arab Emirates.

Rawan Wamidh Hadi (RW)

Faculty of Allied Medical Sciences, Applied Science Private University, Amman, Jordan.

Asma Ismail Mahmod (AI)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman, Jordan.

Classifications MeSH